Current allegations in the GLP-1 litigation commonly involve claims that: These allegations are not limited to Victoza, but Victoza has become part of this broader litigation because its mechanism of action overlaps with other GLP-1 medications now facing coordinated claims
No matter the version of semaglutide, taking it consistently and as directed is essential for ensuring the medication works as well as possible
What is obesity
Its a safe, highly effective way to relieve symptoms caused by an enlarged prostatewith no incisions, minimal bleeding and a faster recovery
Cardiovascular Effects GLP-1-based therapies have been associated with slight increases in heart rate, which may be a concern for adolescents with underlying cardiovascular conditions
[1] Adverse effects [edit] Safety and dosing trials showed that the incidence of adverse events in orforglipron-treated participants was 6289%, mostly from gastrointestinal discomfort (4470% with orforglipron, 18% with placebo)